Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Expenses

	December 31,
(In thousands)	2024			2023
Research and Development:
Employee expense	$	4,984		$	4,004
Clinical		5,345			7,567
Product		1,147			1,443
Other		773			569
Total research and development		12,249			13,583
Selling, general and administrative expense
Employee expense	$	6,285			7,436
Professional fees		2,451			1,729
Occupancy		626			631
Insurance		655			724
Other		1,560			1,135
Total selling, general and administrative expense		11,577			11,655
Loss from Operations		23,826			25,238
Adjustments and reconciling Items		(2,007	)		(1,722	)
Net Loss	$	21,819		$	23,516